Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer

NCT02597179 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02597179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02597179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2012
Completion date
July 31, 2019
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer